Opioids Global Market Report 2026

Description

Opioids are a class of potent medications derived from or synthesized from the opium poppy plant that act on the nervous system to relieve pain. They are highly effective in treating moderate to severe pain, including post-surgical pain, cancer-related pain, and chronic pain conditions, as well as managing coughing and diarrhea.

The main types of opioid products include methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. Methadone is an opioid used in medication-assisted treatment (MAT) programs to help individuals reduce or stop their use of heroin or other opioids. Opioids act through various receptor bindings, including strong agonists and mild to moderate agonists. They are administered for multiple indications, such as inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain, and are available through hospitals, retail pharmacies, and online pharmacies. These drugs are used in various applications, including pain management, cough treatment, and diarrhea management.

Tariffs have impacted the opioids market by increasing costs associated with active pharmaceutical ingredients, excipients, and cross-border manufacturing of controlled drugs, particularly affecting synthetic opioids such as fentanyl and oxycodone. Supply chain disruptions and higher import duties have strained pharmaceutical manufacturers, especially in regions dependent on API imports such as Asia-Pacific and parts of Europe. Hospital and retail pharmacy segments have experienced pricing pressures and procurement delays due to tariff-induced cost inflation. However, tariffs have also encouraged localized production, contract manufacturing expansion, and investment in domestic API manufacturing, supporting long-term supply resilience and regulatory compliance within key markets.

The opioids market research report is one of a series of new reports from The Business Research Company that provides opioids market statistics, including opioids industry global market size, regional shares, competitors with a opioids market share, detailed opioids market segments, market trends and opportunities, and any further data you may need to thrive in the opioids industry. This opioids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The opioids market size has grown steadily in recent years. It will grow from $23.98 billion in 2025 to $24.63 billion in 2026 at a compound annual growth rate (CAGR) of 2.7%. The growth in the historic period can be attributed to post-surgical pain prevalence, rising cancer incidence, widespread opioid prescription practices, limited availability of alternative pain therapies, strong hospital-based opioid usage.

The opioids market size is expected to see steady growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to growth in chronic pain population, development of safer opioid formulations, expansion of palliative care services, increasing regulatory clarity for controlled substances, rising demand for effective pain management in aging populations. Major trends in the forecast period include precision-guided opioid therapy development, digital prescription monitoring integration, shift toward abuse-deterrent formulations, expansion of long-acting and extended-release opioids, growing use of opioids in oncology pain management.

The rising prevalence of chronic diseases is expected to drive the growth of the opioids market in the coming years. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-term medical conditions that generally progress slowly and persist over extended periods. These conditions often last for years or even a lifetime and typically do not resolve on their own. The growing prevalence of chronic diseases is a key factor supporting the opioids market, as an increasing number of people experience chronic pain and require effective pain management. Opioids are used in chronic disease management to provide significant pain relief. For instance, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes, reflecting an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is propelling the growth of the opioids market.

Major companies in the opioids market are concentrating on developing advanced drug solutions to strengthen their market position. The creation of innovative medications helps address medical needs while advancing healthcare and scientific understanding. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of opioid addiction treatments, announced that the US Food and Drug Administration approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration for the treatment of moderate to severe opioid use disorder (OUD). It is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD and the first buprenorphine injectable using FluidCrystal Injection Depot Technology. Patients on oral buprenorphine can be safely transitioned to equivalent doses following prescribing guidelines.

In March 2023, Indivior PLC, a US-based specialty pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition provides Indivior with a comprehensive treatment platform to address the ongoing opioid crisis in the United States. It also strengthens Indivior's addiction treatment and scientific portfolio by integrating Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a US-based developer of therapies for opioid overdose and addiction management.

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the opioids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Opioids Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses opioids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for opioids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The opioids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Type: Methadone; Codeine; Fentanyl; Oxycodone; Morphine; Hydrocodone; Other Product Types
2) By Receptor Binding: Strong Agonist; Mild To Moderate Agonist
3) By Basis Of Indication: Inflammatory Condition; Musculoskeletal Pain; Neuropathic Pain; Cancer Pain
4) By Distribution Channel: Hospital; Retail Pharmacies; Online Pharmacies
5) By Application: Pain Management; Cough Treatment; Diarrhea Treatment
Subsegments:
1) By Methadone: Methadone Tablets; Methadone Oral Solution
2) By Codeine: Codeine Phosphate Tablets; Codeine Liquid Formulations
3) By Fentanyl: Fentanyl Patch; Fentanyl Injection; Fentanyl Sublingual Tablets
4) By Oxycodone: Oxycodone Tablets; Oxycodone Extended-Release Formulations
5) By Morphine: Morphine Sulfate Tablets; Morphine Injection; Morphine Extended-Release Capsules
6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets; Hydrocodone Liquid Formulations
7) By Other Product Types: Buprenorphine; Tramadol; Other Combination Products
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; AbbVie Inc.; Sanofi S.A; AstraZeneca Plc; Viatris Inc.; Teva Pharmaceutical Industries Limited; Sandoz Inc.; Sun Pharmaceutical Industries Limited; Aurobindo Pharma Limited; Purdue Pharma L.P.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals plc; Endo Pharmaceuticals Inc.; Amneal Pharmaceuticals Inc.; Mallinckrodt Pharmaceuticals plc; Alkermes plc; Lannett Co Inc.; Par Pharmaceutical Inc.; Mayne Pharma Group Ltd.; Cephalon LLC; Insys Therapeutics Inc.; Janssen Pharmaceuticals Inc.; Rhodes Pharmaceuticals L.P; KVK Tech Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MOPIO01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Opioids Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Opioids Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Opioids Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Opioids Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Sustainability, Climate Tech & Circular Economy
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Precision-Guided Opioid Therapy Development
- 4.2.2 Digital Prescription Monitoring Integration
- 4.2.3 Shift Toward Abuse-Deterrent Formulations
- 4.2.4 Expansion Of Long-Acting And Extended-Release Opioids
- 4.2.5 Growing Use Of Opioids In Oncology Pain Management

5. Opioids Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Pain Management Clinics
5.3 Oncology Centers
5.4 Rehabilitation Centers
5.5 Home Healthcare Providers

6. Opioids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Opioids Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Opioids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Opioids Market Size, Comparisons And Growth Rate Analysis
7.3. Global Opioids Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Opioids Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Opioids Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Opioids Market Segmentation

9.1. Global Opioids Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types
9.2. Global Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Strong Agonist, Mild To Moderate Agonist
9.3. Global Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain
9.4. Global Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital, Retail Pharmacies, Online Pharmacies
9.5. Global Opioids Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pain Management, Cough Treatment, Diarrhea Treatment
9.6. Global Opioids Market, Sub-Segmentation Of Methadone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Methadone Tablets, Methadone Oral Solution
9.7. Global Opioids Market, Sub-Segmentation Of Codeine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Codeine Phosphate Tablets, Codeine Liquid Formulations
9.8. Global Opioids Market, Sub-Segmentation Of Fentanyl, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets
9.9. Global Opioids Market, Sub-Segmentation Of Oxycodone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oxycodone Tablets, Oxycodone Extended-Release Formulations
9.10. Global Opioids Market, Sub-Segmentation Of Morphine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules
9.11. Global Opioids Market, Sub-Segmentation Of Hydrocodone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations
9.12. Global Opioids Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Buprenorphine, Tramadol, Other Combination Products

10. Opioids Market Regional And Country Analysis

10.1. Global Opioids Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Opioids Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Opioids Market

11.1. Asia-Pacific Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Opioids Market

12.1. China Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Opioids Market

13.1. India Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Opioids Market

14.1. Japan Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Opioids Market

15.1. Australia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Opioids Market

16.1. Indonesia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Opioids Market

17.1. South Korea Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Opioids Market

18.1. Taiwan Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Opioids Market

19.1. South East Asia Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Opioids Market

20.1. Western Europe Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Opioids Market

21.1. UK Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Opioids Market

22.1. Germany Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Opioids Market

23.1. France Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Opioids Market

24.1. Italy Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Opioids Market

25.1. Spain Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Opioids Market

26.1. Eastern Europe Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Opioids Market

27.1. Russia Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Opioids Market

28.1. North America Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Opioids Market

29.1. USA Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Opioids Market

30.1. Canada Opioids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Opioids Market

31.1. South America Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Opioids Market

32.1. Brazil Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Opioids Market

33.1. Middle East Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Opioids Market

34.1. Africa Opioids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Opioids Market, Segmentation By Product Type, Segmentation By Receptor Binding, Segmentation By Basis Of Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Opioids Market Regulatory and Investment Landscape

36. Opioids Market Competitive Landscape And Company Profiles

36.1. Opioids Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Opioids Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Opioids Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

37. Opioids Market Other Major And Innovative Companies

Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd.

38. Global Opioids Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Opioids Market

40. Opioids Market High Potential Countries, Segments and Strategies

40.1 Opioids Market In 2030 - Countries Offering Most New Opportunities
40.2 Opioids Market In 2030 - Segments Offering Most New Opportunities
40.3 Opioids Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer